Medical Diagnostics & Clinical Scoring

UPDRS (Parkinson's Rating Scale)

Use the Unified Parkinson's Disease Rating Scale (UPDRS) to longitudinally track the progression of motor and non-motor symptoms.

Total UPDRS Score
0
AssessmentMild Disease

Calculated locally in your browser. Fast, secure, and private.

UPDRS Overview

The Unified Parkinson's Disease Rating Scale (UPDRS) is the most comprehensive, widely utilized clinical tool in the world for evaluating the longitudinal course of Parkinson's disease. Developed in the 1980s, it provides a multidimensional assessment that tracks both the motor and non-motor burdens of the disease.

The Four Parts of the UPDRS

The scale is highly detailed and requires both patient interviews and a physical examination by a trained clinician. It is divided into four main sections:

  • Part I (Mentation, Behavior, and Mood): Assesses cognitive decline, hallucinations, depression, and motivation.
  • Part II (Activities of Daily Living): Evaluates speech, swallowing, handwriting, dressing, hygiene, falling, and walking.
  • Part III (Motor Examination): The physical exam component, testing tremor at rest, rigidity, finger tapping, posture, gait, and bradykinesia (slowness of movement).
  • Part IV (Complications of Therapy): Tracks the severe side effects of levodopa therapy, including dyskinesias (involuntary movements) and motor fluctuations ('ON/OFF' periods).

Total Score = Sum of individual ratings across all 4 parts (Maximum 199 points)

Frequently Asked Questions

The Movement Disorder Society (MDS) published a revised, updated version of the scale in 2008 known as the MDS-UPDRS. It was redesigned to better capture non-motor symptoms (like sleep and autonomic issues) and to resolve ambiguities in the original scale's instructions.

Often, only Part III (the Motor Exam) is performed during standard, rapid clinical visits to gauge how well the patient's current medication dose is working. The full UPDRS takes 20-30 minutes and is used more frequently in specialized movement disorder centers and clinical trials.

A higher score indicates greater disease severity and a heavier symptom burden. 0 represents no disability, while the maximum score of 199 represents total, severe disability and total dependence on caregivers.